John Libbey Eurotext

Pharmacological monitoring of antiepileptic drugs in epilepsy patients on haemodialysis Volume 22, issue 1, February 2020

Figures

  • Figure 1
  • Figure 2

Tables

Authors
1 Department of Neurology, Nagoya University Graduate School of Medicine, Aichi,
2 Department of Laboratory Medicine, Nagoya University Hospital, Aichi,
3 Department of Neurology, Masuko Memorial Hospital, Aichi,
4 Department of Neurology, Nagoya Daini Red Cross Hospital, Aichi,
5 Department of Nephrology, Aoi Central Hospital, Aichi,
6 Department of Neurology, Okazaki City Hospital, Aichi,
7 Department of Neurology, Anjo Kosei Hospital, Aichi,
8 Department of Neurology, Miai Clinic, Aichi,
9 Department of Nephrology, Aoi Clinic, Aichi,
10 Department of Neurology, Kamiiida Daiichi General Hospital, Aichi,
11 National Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka,
12 Department of Nephrology, Masuko Memorial Hospital, Aichi,
13 Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan
* Correspondence: Masahisa Katsuno 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan

Aims

To retrospectively evaluate the pharmacological profiles of antiepileptic drugs (AEDs) in epilepsy patients during haemodialysis using therapeutic drug monitoring data.